Jeffrey P. George - May 9, 2023 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
May 9, 2023
Transactions value $
$0
Form type
4
Date filed
5/11/2023, 04:15 PM
Previous filing
Feb 23, 2023
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +80.1K +70.94% 193K May 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Award $0 +76.5K $0.00 76.5K May 9, 2023 Class A Common Stock 76.5K Direct F1, F2
transaction AMRX Restricted Stock Units Options Exercise $0 -80.1K -100% $0.00* 0 May 10, 2023 Class A Common Stock 80.1K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
F3 On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney